Global Delivery of Human Papillomavirus Vaccines

Pediatr Clin North Am. 2016 Feb;63(1):81-95. doi: 10.1016/j.pcl.2015.08.004.

Abstract

Worldwide, cervical cancer is the fourth most common cancer among women. Human papillomavirus (HPV) vaccination, if broadly implemented, has the potential to significantly reduce global rates of morbidity and mortality associated with cervical and other HPV-related cancers. More than 100 countries around the world have licensed HPV vaccines. As of February, 2015, there were an estimated 80 national HPV immunization programs and 37 pilot programs. This article discusses global implementation of HPV vaccination programs and issues such as vaccine financing and different approaches to HPV vaccine delivery.

Keywords: Global; HPV; Human papillomavirus; Immunization; Progress; Vaccine.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Community Health Services
  • Female
  • Global Health*
  • Humans
  • Immunization Programs*
  • Incidence
  • Male
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines*
  • School Health Services
  • Uterine Cervical Neoplasms / epidemiology

Substances

  • Papillomavirus Vaccines